{"id":"transdermal-17beta-estradiol-progesterone","safety":{"commonSideEffects":[{"rate":"10-20","effect":"Breast tenderness"},{"rate":"5-15","effect":"Headache"},{"rate":"5-10","effect":"Nausea"},{"rate":"5-15","effect":"Vaginal bleeding or spotting"},{"rate":"5-10","effect":"Skin irritation at patch site"},{"rate":"5-10","effect":"Bloating"}]},"_chembl":{"chemblId":"CHEMBL1697724","moleculeType":"Small molecule","molecularWeight":"448.51"},"_dailymed":null,"mechanism":{"_ai_source":"anthropic-haiku","explanation":"17Beta-estradiol is the primary form of estrogen that binds to estrogen receptors (ERα and ERβ) throughout the body, while progesterone acts on progesterone receptors to provide endometrial protection and additional hormonal effects. Together, they mimic the natural hormonal cycle and alleviate menopausal symptoms while reducing certain long-term health risks associated with estrogen deficiency.","oneSentence":"This transdermal combination replaces estrogen and progesterone to restore hormonal balance in menopausal or postmenopausal women.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:39:44.832Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Menopausal symptoms (hot flashes, night sweats, vaginal dryness)"},{"name":"Osteoporosis prevention in postmenopausal women"}]},"trialDetails":[{"nctId":"NCT06533865","phase":"PHASE3","title":"Romosozumab as an Adjunct to Physiologic Estrogen Replacement in Functional Hypothalamic Amenorrhea","status":"RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2025-03-19","conditions":"FHA (Functional Hypothalamic Amenorrhea)","enrollment":114},{"nctId":"NCT07496294","phase":"NA","title":"Comparison of Oral Dydrogesterone and Vaginal Progesterone in Menopausal Hormone Therapy","status":"NOT_YET_RECRUITING","sponsor":"Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital","startDate":"2026-04","conditions":"Menopausal Women, Menopausal Symptom Relief, Hormone Therapy","enrollment":200},{"nctId":"NCT06851754","phase":"PHASE3","title":"Hormone Replacement Therapy in Adolescents With Premature Ovarian Insufficiency","status":"RECRUITING","sponsor":"Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)","startDate":"2025-07-17","conditions":"Premature Ovarian Insufficiency","enrollment":185},{"nctId":"NCT06497894","phase":"PHASE4","title":"No More Sleepless Nights in Perimenopause","status":"RECRUITING","sponsor":"Insel Gruppe AG, University Hospital Bern","startDate":"2026-01-01","conditions":"Insomnia, Menopause","enrollment":54},{"nctId":"NCT06866119","phase":"","title":"Effects of Estrogen on Heart Health in Women With Primary Ovarian Insufficiency","status":"NOT_YET_RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2026-03-01","conditions":"Primary Ovarian Insufficiency, Premature Menopause, Metabolic Complications","enrollment":45},{"nctId":"NCT04112368","phase":"PHASE4","title":"Cyclical Neuroactive Steroid Changes, Arousal, and Proximal Suicide Risk: An Experimental Approach","status":"COMPLETED","sponsor":"University of Illinois at Chicago","startDate":"2020-09-15","conditions":"Suicidal Ideation","enrollment":124},{"nctId":"NCT05388656","phase":"PHASE4","title":"Estrogen Variability and Irritability During the Menopause Transition","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2022-06-15","conditions":"Menopause, Irritable Mood","enrollment":40},{"nctId":"NCT05704036","phase":"PHASE4","title":"Estrogen Supplementation and Bone Health in Women With CF","status":"RECRUITING","sponsor":"Johns Hopkins University","startDate":"2023-05-02","conditions":"Cystic Fibrosis, Hypoestrogenism","enrollment":75},{"nctId":"NCT06610305","phase":"PHASE4","title":"Ovarian Hormone Withdrawal, Anhedonia, and Reward Sensitivity in Women With Premenstrual Exacerbations of Depression","status":"RECRUITING","sponsor":"University of North Carolina, Chapel Hill","startDate":"2024-09-02","conditions":"Major Depressive Disorder","enrollment":75},{"nctId":"NCT03689543","phase":"PHASE2","title":"Estrogen Receptor Beta and Mood","status":"COMPLETED","sponsor":"National Institute of Mental Health (NIMH)","startDate":"2019-05-23","conditions":"Perimenopause-Related Depression","enrollment":74},{"nctId":"NCT06455969","phase":"PHASE4","title":"Adaptions and Resiliency to Multi-Stressor OpeRations","status":"RECRUITING","sponsor":"Bradley Nindl","startDate":"2024-07-15","conditions":"Musculoskeletal Injury, Hypogonadism","enrollment":120},{"nctId":"NCT06306404","phase":"PHASE4","title":"Sleeping Through Menopause","status":"NOT_YET_RECRUITING","sponsor":"VU University of Amsterdam","startDate":"2025-10-01","conditions":"Menopause, Insomnia","enrollment":222},{"nctId":"NCT03875378","phase":"PHASE2","title":"Transdermal Estrogen in Women With Anorexia Nervosa","status":"RECRUITING","sponsor":"Pouneh K. Fazeli, MD","startDate":"2020-08-28","conditions":"Anorexia Nervosa","enrollment":66},{"nctId":"NCT04833140","phase":"PHASE3","title":"Estrogen Administration for the Treatment of NASH in Postmenopausal Women","status":"RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2021-12-02","conditions":"NASH - Nonalcoholic Steatohepatitis","enrollment":60},{"nctId":"NCT06856174","phase":"PHASE4","title":"Menopausal HT for Women Living With HIV (HoT)","status":"NOT_YET_RECRUITING","sponsor":"Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections","startDate":"2026-01-19","conditions":"HIV Infection, Menopause","enrollment":105},{"nctId":"NCT03740204","phase":"PHASE2","title":"The Role of Estrogen in the Neurobiology of Eating Disorders","status":"RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2019-06-13","conditions":"Eating Disorders, Hypoestrogenemia","enrollment":120},{"nctId":"NCT03018366","phase":"PHASE2","title":"Atherosclerosis, Immune Mediated Inflammation and Hypoestrogenemia in Young Women","status":"COMPLETED","sponsor":"Cedars-Sinai Medical Center","startDate":"2017-01-01","conditions":"Estrogen Deficiency, Cardiovascular Disease (CVD), Functional Hypothalamic Amenorrhea","enrollment":29},{"nctId":"NCT06715514","phase":"NA","title":"Menopausal Hormone Therapy, GLP-1 Agonists, and Glucose and Energy Homeostasis in Postmenopausal Women With Diabetes","status":"RECRUITING","sponsor":"Lia Bally","startDate":"2025-02-18","conditions":"Menopause, Type 2 Diabetes","enrollment":96},{"nctId":"NCT05282277","phase":"PHASE4","title":"Examining the Effects of Estradiol on Neural and Molecular Response to Reward","status":"RECRUITING","sponsor":"University of North Carolina, Chapel Hill","startDate":"2022-04-20","conditions":"Depression, Psychosis, Anhedonia","enrollment":103},{"nctId":"NCT05903820","phase":"PHASE4","title":"Rhythmic Estradiol and Bone Health","status":"COMPLETED","sponsor":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","startDate":"2023-07-19","conditions":"Osteoporosis Risk, Menopause","enrollment":48},{"nctId":"NCT04597099","phase":"EARLY_PHASE1","title":"Androgen Blockade and Progesterone Augmentation of Gonadotropin Secretion","status":"UNKNOWN","sponsor":"University of Virginia","startDate":"2022-10-26","conditions":"PCOS, Polycystic Ovary Syndrome","enrollment":10},{"nctId":"NCT05678192","phase":"PHASE1","title":"Effect of Menopausal Hormone Therapy on Immune System Parameters","status":"COMPLETED","sponsor":"Federal State Budget Institution Research Center for Obstetrics, Gynecology and Perinatology Ministry of Healthcare","startDate":"2021-12-01","conditions":"Last Period Not Earlier Than 6 Months Ago","enrollment":40},{"nctId":"NCT00837616","phase":"PHASE4","title":"Estrogen Dosing in Turner Syndrome: Pharmacology and Metabolism","status":"COMPLETED","sponsor":"Nemours Children's Clinic","startDate":"2009-01","conditions":"Turner Syndrome, Hypogonadism, Premature Ovarian Failure","enrollment":41},{"nctId":"NCT00001259","phase":"PHASE1","title":"A Treatment Study for Premenstrual Syndrome (PMS)","status":"COMPLETED","sponsor":"National Institute of Mental Health (NIMH)","startDate":"1992-08-11","conditions":"Premenstrual Syndrome, Menstruation Disturbances","enrollment":60},{"nctId":"NCT05737329","phase":"PHASE1, PHASE2","title":"Efficacy, Safety, and Tolerability of Higher Doses Estrogen Therapy in Women With Premature Ovarian Insufficiency","status":"UNKNOWN","sponsor":"Federal State Budget Institution Research Center for Obstetrics, Gynecology and Perinatology Ministry of Healthcare","startDate":"2019-03-01","conditions":"Primary Ovarian Insufficiency","enrollment":80},{"nctId":"NCT04021017","phase":"PHASE1","title":"PRE-GAiN Bone Health Pilot Study","status":"WITHDRAWN","sponsor":"University of Saskatchewan","startDate":"2020-01-21","conditions":"Anorexia Nervosa","enrollment":""},{"nctId":"NCT03498313","phase":"PHASE4","title":"Unique Effects of Perimenstrual Estradiol or Progesterone Supplementation on Perimenstrual Suicidality","status":"COMPLETED","sponsor":"University of Illinois at Chicago","startDate":"2018-07-27","conditions":"Suicidal Ideation","enrollment":60},{"nctId":"NCT00001322","phase":"PHASE1, PHASE2","title":"The Effects of Reproductive Hormones on Mood and Behavior","status":"COMPLETED","sponsor":"National Institute of Mental Health (NIMH)","startDate":"1994-06-09","conditions":"Healthy Volunteers","enrollment":100},{"nctId":"NCT02122198","phase":"NA","title":"Vascular Mechanisms for the Effects of Loss of Ovarian Hormone Function on Cognition in Women","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2014-09-08","conditions":"Cognitive Impairment, Executive Dysfunction, Endothelial Dysfunction","enrollment":17},{"nctId":"NCT00088153","phase":"PHASE2, PHASE3","title":"Effects of Anorexia Nervosa on Bone Mass in Adolescents","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2003-07","conditions":"Anorexia Nervosa","enrollment":110},{"nctId":"NCT01301183","phase":"PHASE3","title":"Effects of Anorexia Nervosa on Peak Bone Mass","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2011-02","conditions":"Anorexia Nervosa","enrollment":75},{"nctId":"NCT00946192","phase":"PHASE3","title":"Fat Mediated Modulation of Reproductive and Endocrine Function in Young Athletes","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2009-05","conditions":"Exercise-related Amenorrhea","enrollment":121},{"nctId":"NCT03003949","phase":"PHASE4","title":"The Menopause Transition: Estrogen Variability, Stress Reactivity and Mood","status":"TERMINATED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2017-01-24","conditions":"Perimenopausal Disorder, Stress, Emotional","enrollment":82},{"nctId":"NCT04190927","phase":"PHASE4","title":"A New Hormone Replacement Paradigm: Physiologic Restoration Study","status":"UNKNOWN","sponsor":"Women's Hormone Network","startDate":"2020-06-01","conditions":"Menopause, Perimenopausal Disorder, Menopause Related Conditions","enrollment":100},{"nctId":"NCT02255175","phase":"PHASE4","title":"Perimenopausal Effects of Estradiol on Reward Responsiveness","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2015-10-01","conditions":"Perimenopausal Depression","enrollment":64},{"nctId":"NCT03868202","phase":"PHASE2","title":"Follicle Stimulating Hormone (FSH) Glycosylation in Women: Effect of Estradiol","status":"UNKNOWN","sponsor":"Eastern Virginia Medical School","startDate":"2019-07-03","conditions":"Follicle Stimulating Hormone Glycosylation, Urinary FSH21/FSH24 Ratio, Estradiol Effect","enrollment":10},{"nctId":"NCT02922348","phase":"PHASE3","title":"Hormone Replacement for Premature Ovarian Insufficiency","status":"WITHDRAWN","sponsor":"University of Pennsylvania","startDate":"2016-03-01","conditions":"Primary Ovarian Insufficiency","enrollment":""},{"nctId":"NCT03720847","phase":"PHASE4","title":"Effect of Perimenstrual Ovarian Steroid Supplementation on Perimenstrual Suicidality","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2016-12-31","conditions":"Suicidal Ideation","enrollment":30},{"nctId":"NCT02486757","phase":"EARLY_PHASE1","title":"Investigation of Female Reproductive Hormone Dynamics During Adolescence","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2015-04","conditions":"Menstruation Disturbances","enrollment":9},{"nctId":"NCT00066157","phase":"PHASE2, PHASE3","title":"Alzheimer's Disease: Therapeutic Potential of Estrogen","status":"COMPLETED","sponsor":"University of Wisconsin, Madison","startDate":"2001-09","conditions":"Alzheimer Disease","enrollment":42},{"nctId":"NCT01308814","phase":"PHASE2, PHASE3","title":"Perimenopausal Estrogen Replacement Therapy Study","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2010-10","conditions":"Perimenopause, Menopause, Depression","enrollment":172},{"nctId":"NCT01546454","phase":"NA","title":"Relationship Between the Menstrual Cycle and Heart Disease in Women","status":"COMPLETED","sponsor":"Oregon Health and Science University","startDate":"2012-02","conditions":"Coronary Heart Disease","enrollment":5},{"nctId":"NCT02524561","phase":"NA","title":"KEEPS Mammographic Density And Breast Health Ancillary Study","status":"COMPLETED","sponsor":"Brigham and Women's Hospital","startDate":"2005-09","conditions":"Mammographic Density, Abnormal Mammogram","enrollment":517},{"nctId":"NCT01023178","phase":"NA","title":"Comparison of Transdermal and Oral Estrogens in Adolescent Girls With Ovarian Failure","status":"COMPLETED","sponsor":"Stanford University","startDate":"2007-02","conditions":"Ovarian Failure, Premature","enrollment":20},{"nctId":"NCT02467673","phase":"PHASE2","title":"Nanoparticulate Versus Micronized Steroids Delivery for Transdermal Hormone Replacement Therapy","status":"COMPLETED","sponsor":"University Potiguar","startDate":"2012-01","conditions":"Menopausal Syndrome","enrollment":185},{"nctId":"NCT01381016","phase":"NA","title":"Estrogen Sensitivity and Ovulatory Dysfunction in Obesity","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2011-06","conditions":"Obesity, Infertility","enrollment":30},{"nctId":"NCT00361075","phase":"PHASE4","title":"Midlife Cholesterol Study","status":"COMPLETED","sponsor":"Northwestern University","startDate":"1998-07","conditions":"Menopause, Postmenopause, Premenopause","enrollment":120},{"nctId":"NCT01432028","phase":"NA","title":"Pharmacogenetic Study of Different Hormone Therapies in Recent Menopause Women","status":"COMPLETED","sponsor":"Denusa Wiltgen","startDate":"2007-03","conditions":"Postmenopause","enrollment":90},{"nctId":"NCT02033512","phase":"PHASE2","title":"TRANSDERMAL HRT RELIEVING POSTMENOPAUSAL SYMPTOMS","status":"COMPLETED","sponsor":"University Potiguar","startDate":"2003-01","conditions":"Menopause","enrollment":66},{"nctId":"NCT00258076","phase":"PHASE1","title":"A Study to Evaluate the Hormone Exposure From Multiple Commercial Lots of ORTHO EVRA (a Transdermal Contraceptive Patch)","status":"COMPLETED","sponsor":"Johnson & Johnson Pharmaceutical Research & Development, L.L.C.","startDate":"2004-04","conditions":"Contraception, Female Contraception","enrollment":53},{"nctId":"NCT00864214","phase":"PHASE1","title":"A Pharmacokinetic Evaluation of Bioidentical Compounded Estrogen Cream and Natural Progesterone","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2008-06","conditions":"Menopause","enrollment":40},{"nctId":"NCT00127075","phase":"PHASE3","title":"POPART'MUS: Prevention of Post Partum Relapses With Progestin and Estradiol in Multiple Sclerosis","status":"UNKNOWN","sponsor":"Hospices Civils de Lyon","startDate":"2005-06","conditions":"Multiple Sclerosis","enrollment":300},{"nctId":"NCT01123538","phase":"PHASE4","title":"Progestagen Type in Postmenopausal Hormone Therapy and Blood Gene Expression Profile","status":"UNKNOWN","sponsor":"University Hospital of North Norway","startDate":"2008-12","conditions":"Pharmacogenomics, Systems Biology","enrollment":40},{"nctId":"NCT00258063","phase":"PHASE1","title":"A Study to Evaluate the Exposure of Norelgestromin and Ethinyl Estradiol From Commercial Lots of EVRA (a Transdermal Contraceptive Patch Manufactured by LOHMANN Therapie-Systeme) and CILEST (an Oral Contraceptive)","status":"COMPLETED","sponsor":"Johnson & Johnson Pharmaceutical Research & Development, L.L.C.","startDate":"2004-05","conditions":"Contraception, Female Contraception","enrollment":60},{"nctId":"NCT00254865","phase":"PHASE1","title":"A Comparative Pharmacokinetic Study of ORTHO EVRA (a Transdermal Contraceptive Patch) and CILEST (an Oral Contraceptive) in Healthy Female Volunteers","status":"COMPLETED","sponsor":"Johnson & Johnson Pharmaceutical Research & Development, L.L.C.","startDate":"2002-08","conditions":"Contraception, Female Contraception","enrollment":34},{"nctId":"NCT00236769","phase":"PHASE3","title":"A Study of Efficacy and Safety With the Transdermal Contraceptive System.","status":"COMPLETED","sponsor":"Johnson & Johnson Pharmaceutical Research & Development, L.L.C.","startDate":"1997-11","conditions":"Contraception, Female Contraception","enrollment":1751},{"nctId":"NCT01087593","phase":"NA","title":"Estrogens Effect on Pain in Postmenopausal Women Suffering of Fibromyalgia","status":"TERMINATED","sponsor":"Ostergotland County Council, Sweden","startDate":"2001-08","conditions":"Fibromyalgia","enrollment":29},{"nctId":"NCT00154180","phase":"PHASE4","title":"Kronos Early Estrogen Prevention Study (KEEPS)","status":"UNKNOWN","sponsor":"Kronos Longevity Research Institute","startDate":"2005-09","conditions":"Menopause, Arteriosclerosis","enrollment":728},{"nctId":"NCT00732693","phase":"PHASE4","title":"Evaluation of Physiologic and Standard Sex Steroid Replacement Regimens in Women With Premature Ovarian Failure","status":"COMPLETED","sponsor":"University of Edinburgh","startDate":"2002-02","conditions":"Premature Ovarian Failure","enrollment":42}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Vivelle Dot transdermal patch","Prometrium"],"phase":"phase_3","status":"active","brandName":"Transdermal 17Beta-estradiol, progesterone","genericName":"Transdermal 17Beta-estradiol, progesterone","companyName":"Massachusetts General Hospital","companyId":"massachusetts-general-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"This transdermal combination replaces estrogen and progesterone to restore hormonal balance in menopausal or postmenopausal women. Used for Menopausal symptoms (hot flashes, night sweats, vaginal dryness), Osteoporosis prevention in postmenopausal women.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}